Skip to main content

Table 3 Overview of modeling results

From: FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients

Performance of model PFS OS
FDG PET-model, c-index (95% CI)
Training
Validation
0.67 (0.52–0.82)
0.66 ( 0.57–0.78)
0.72 (0.62–0.84)
0.47 (0.36–0.62)
CT-model, c-index (95% CI)
Training
Validation
0.66 (0.56–0.76)
0.54 (0.44–0.67)
0.71 (0.59–0.80)
0.59 (0.47–0.74)
SUVmax, c-index (95% CI)
Training
Validation
0.55 (0.44–0.60)
0.54 (0.42–0.68)
SUVmean, c-index (95% CI)
Training
Validation
0.52 (0.40–0.66)
0.52 (0.40–0.66)
Volume, c-index (95% CI)
Training
Validation
0.60 (0.49–0.73)
0.57 (0.48–0.67)
0.62 (0.52–0.72)
0.63 (0.50–0.75)
  1. PFS progression-free-survival, OS overall survival